According to some estimates, more than 15 million Americans have taken Ozempic, Wegovy, or a related medication
Medvi does not manufacture medication but coordinates between clinicians and pharmacy partners for fulfillment and patient support
Statistical Data Analysis The data shows some clear patterns: Women faced a 219% higher risk of anxiety symptoms than non-users Young adults aged 18-49 were more likely to experience psychiatric effects People who used the medication longer (180+ days) saw fewer anxiety cases just 2.93 per 1,000 person-years Comparison with Other GLP-1 Medications GLP-1 medications show different patterns in our data
Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019
In the pivotal MAESTRO-NASH of THR agonist Rezdiffra, steatohepatitis resolution was seen in 30% of patients on a 100mg dose, compared to 10% with placebo, after 52 weeks